161 related articles for article (PubMed ID: 15033991)
1. Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy.
Sadlier DM; Connolly SB; Kieran NE; Roxburgh S; Brazil DP; Kairaitis L; Wang Y; Harris DC; Doran P; Brady HR
J Biol Chem; 2004 Jul; 279(28):29670-80. PubMed ID: 15033991
[TBL] [Abstract][Full Text] [Related]
2. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2.
He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C
Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells.
Liu Y; Bi X; Xiong J; Han W; Xiao T; Xu X; Yang K; Liu C; Jiang W; He T; Yu Y; Li Y; Zhang J; Zhang B; Zhao J
Mol Ther; 2019 May; 27(5):1051-1065. PubMed ID: 30853453
[TBL] [Abstract][Full Text] [Related]
5. The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis.
Seo E; Kim WY; Hur J; Kim H; Nam SA; Choi A; Kim YM; Park SH; Chung C; Kim J; Min S; Myung SJ; Lim DS; Kim YK
Sci Rep; 2016 Aug; 6():31931. PubMed ID: 27550469
[TBL] [Abstract][Full Text] [Related]
6. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Protein Cystathionine β-Synthase During Kidney Injury Promotes Renal Tubulointerstitial Fibrosis.
Yuan X; Zhang J; Xie F; Tan W; Wang S; Huang L; Tao L; Xing Q; Yuan Q
Kidney Blood Press Res; 2017; 42(3):428-443. PubMed ID: 28750410
[TBL] [Abstract][Full Text] [Related]
8. DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.
Higgins DF; Lappin DW; Kieran NE; Anders HJ; Watson RW; Strutz F; Schlondorff D; Haase VH; Fitzpatrick JM; Godson C; Brady HR
Kidney Int; 2003 Dec; 64(6):2079-91. PubMed ID: 14633130
[TBL] [Abstract][Full Text] [Related]
9. Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis.
Sadlier DM; Ouyang X; McMahon B; Mu W; Ohashi R; Rodgers K; Murray D; Nakagawa T; Godson C; Doran P; Brady HR; Johnson RJ
Kidney Int; 2005 Dec; 68(6):2542-61. PubMed ID: 16316330
[TBL] [Abstract][Full Text] [Related]
10. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
11. Identification of YAP1 as a novel downstream effector of the FGF2/STAT3 pathway in the pathogenesis of renal tubulointerstitial fibrosis.
Li X; Zhang F; Qu L; Xie Y; Ruan Y; Guo Z; Mao Y; Zou Q; Shi M; Xiao Y; Wang Y; Zhou Y; Guo B
J Cell Physiol; 2021 Nov; 236(11):7655-7671. PubMed ID: 33993470
[TBL] [Abstract][Full Text] [Related]
12. Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice.
Powell DW; Bertram CC; Cummins TD; Barati MT; Zheng S; Epstein PN; Klein JB
Nephron Exp Nephrol; 2009; 111(1):e11-9. PubMed ID: 19052473
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular events leading to renal tubulointerstitial fibrosis.
Razzaque MS; Taguchi T
Med Electron Microsc; 2002 Jun; 35(2):68-80. PubMed ID: 12181648
[TBL] [Abstract][Full Text] [Related]
14. The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway.
Li ZL; Lv LL; Wang B; Tang TT; Feng Y; Cao JY; Jiang LQ; Sun YB; Liu H; Zhang XL; Ma KL; Tang RN; Liu BC
FASEB J; 2019 Nov; 33(11):12630-12643. PubMed ID: 31451021
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
16. UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury.
Ke Q; Yuan Q; Qin N; Shi C; Luo J; Fang Y; Xu L; Sun Q; Zen K; Jiang L; Zhou Y; Yang J
Cell Death Dis; 2020 Jan; 11(1):26. PubMed ID: 31932578
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI.
Wang Y; Zhang Z; Shen H; Lu Y; Li H; Ren X; Wu G
J Recept Signal Transduct Res; 2008; 28(4):413-28. PubMed ID: 18702012
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.
Mizuno S; Matsumoto K; Nakamura T
Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391
[TBL] [Abstract][Full Text] [Related]
20. FTO modulates fibrogenic responses in obstructive nephropathy.
Wang CY; Shie SS; Tsai ML; Yang CH; Hung KC; Wang CC; Hsieh IC; Wen MS
Sci Rep; 2016 Jan; 6():18874. PubMed ID: 26727661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
